AMED Amedisys Inc

Price (delayed)

$92.16

Market cap

$3.01B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.3

Enterprise value

$3.36B

Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for its patients, ...

Highlights
The company's debt fell by 9% YoY
AMED's equity is up by 2.6% since the previous quarter
The quick ratio has increased by 8% QoQ but it has decreased by 4% YoY
The net income has shrunk by 108% YoY
AMED's EPS has plunged by 108% YoY

Key stats

What are the main financial stats of AMED
Market
Shares outstanding
32.67M
Market cap
$3.01B
Enterprise value
$3.36B
Valuations
Price to book (P/B)
2.82
Price to sales (P/S)
1.34
EV/EBIT
46.6
EV/EBITDA
25.85
EV/Sales
1.5
Earnings
Revenue
$2.24B
EBIT
$72.09M
EBITDA
$129.93M
Free cash flow
$131.7M
Per share
EPS
-$0.3
Free cash flow per share
$4.04
Book value per share
$32.68
Revenue per share
$68.6
TBVPS
$21.87
Balance sheet
Total assets
$2.06B
Total liabilities
$940.39M
Debt
$487.21M
Equity
$1.07B
Working capital
$23.21M
Liquidity
Debt to equity
0.46
Current ratio
1.05
Quick ratio
0.95
Net debt/EBITDA
2.68
Margins
EBITDA margin
5.8%
Gross margin
44.3%
Net margin
-0.4%
Operating margin
7%
Efficiency
Return on assets
-0.5%
Return on equity
-0.9%
Return on invested capital
12%
Return on capital employed
4.5%
Return on sales
3.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AMED stock price

How has the Amedisys stock price performed over time
Intraday
-0.32%
1 week
0.01%
1 month
-1.48%
1 year
26.16%
YTD
-3.05%
QTD
-3.05%

Financial performance

How have Amedisys's revenue and profit performed over time
Revenue
$2.24B
Gross profit
$990.87M
Operating income
$156.39M
Net income
-$9.75M
Gross margin
44.3%
Net margin
-0.4%
The company's net margin has shrunk by 108% YoY
The net income has shrunk by 108% YoY
The company's operating margin fell by 16% YoY and by 8% QoQ
AMED's operating income is down by 15% year-on-year and by 7% since the previous quarter

Growth

What is Amedisys's growth rate over time

Valuation

What is Amedisys stock price valuation
P/E
N/A
P/B
2.82
P/S
1.34
EV/EBIT
46.6
EV/EBITDA
25.85
EV/Sales
1.5
AMED's EPS has plunged by 108% YoY
The P/B is 55% less than the 5-year quarterly average of 6.3
AMED's equity is up by 2.6% since the previous quarter
The P/S is 44% less than the 5-year quarterly average of 2.4 but 3.1% more than the last 4 quarters average of 1.3

Efficiency

How efficient is Amedisys business performance
The ROA has dropped by 108% year-on-year
The ROE has plunged by 108% YoY
AMED's ROS has plunged by 61% YoY and by 14% from the previous quarter
The ROIC has plunged by 53% YoY and by 7% from the previous quarter

Dividends

What is AMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMED.

Financial health

How did Amedisys financials performed over time
AMED's total assets is 119% higher than its total liabilities
The company's total liabilities rose by 8% YoY
The quick ratio has increased by 8% QoQ but it has decreased by 4% YoY
The company's debt is 54% lower than its equity
The debt to equity has contracted by 10% YoY and by 2.1% from the previous quarter
The company's debt fell by 9% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.